A detailed history of Fmr LLC transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 9,409,078 shares of TNGX stock, worth $27.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
9,409,078
Previous 9,491,655 0.87%
Holding current value
$27.8 Million
Previous $75.4 Million 7.12%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$6.66 - $10.15 $549,962 - $838,156
-82,577 Reduced 0.87%
9,409,078 $80.7 Million
Q1 2024

May 13, 2024

SELL
$7.51 - $12.88 $2.22 Million - $3.81 Million
-295,695 Reduced 3.02%
9,491,655 $75.4 Million
Q4 2023

Feb 13, 2024

SELL
$6.52 - $12.01 $12.1 Million - $22.3 Million
-1,858,391 Reduced 15.96%
9,787,350 $96.9 Million
Q3 2023

Nov 13, 2023

BUY
$2.93 - $11.26 $3.74 Million - $14.4 Million
1,276,945 Added 12.32%
11,645,741 $131 Million
Q2 2023

Aug 11, 2023

BUY
$2.67 - $4.7 $2.3 Million - $4.04 Million
859,867 Added 9.04%
10,368,796 $34.4 Million
Q1 2023

May 11, 2023

BUY
$3.76 - $8.06 $1.6 Million - $3.43 Million
425,250 Added 4.68%
9,508,929 $37.6 Million
Q4 2022

Feb 13, 2023

BUY
$3.41 - $8.29 $6.97 Million - $17 Million
2,045,339 Added 29.06%
9,083,679 $65.9 Million
Q3 2022

Nov 10, 2022

SELL
$3.25 - $5.46 $1.93 Million - $3.24 Million
-593,577 Reduced 7.78%
7,038,340 $25.5 Million
Q2 2022

Aug 12, 2022

BUY
$3.86 - $8.01 $2.92 Million - $6.06 Million
755,942 Added 10.99%
7,631,917 $34.6 Million
Q1 2022

May 13, 2022

SELL
$7.01 - $10.94 $2.15 Million - $3.35 Million
-306,213 Reduced 4.26%
6,875,975 $52.1 Million
Q4 2021

Feb 14, 2022

BUY
$9.55 - $14.29 $8.88 Million - $13.3 Million
930,275 Added 14.88%
7,182,188 $78.6 Million
Q3 2021

Nov 15, 2021

BUY
$9.56 - $17.3 $59.8 Million - $108 Million
6,251,913 New
6,251,913 $80.8 Million

Others Institutions Holding TNGX

About Tango Therapeutics, Inc.


  • Ticker TNGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 88,067,296
  • Market Cap $260M
  • Description
  • Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...
More about TNGX
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.